100 related articles for article (PubMed ID: 26188320)
21. Pseudo-ternary phase diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by the lipid-film hydration method.
Demana PH; Davies NM; Vosgerau U; Rades T
Int J Pharm; 2004 Feb; 270(1-2):229-39. PubMed ID: 14726138
[TBL] [Abstract][Full Text] [Related]
22. Lipid extrudates as novel sustained release systems for pharmaceutical proteins.
Schulze S; Winter G
J Control Release; 2009 Mar; 134(3):177-85. PubMed ID: 19121347
[TBL] [Abstract][Full Text] [Related]
23. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
[TBL] [Abstract][Full Text] [Related]
24. A method for the incorporation of ovalbumin into immune stimulating complexes prepared by the hydration method.
Könnings S; Copland MJ; Davies NM; Rades T
Int J Pharm; 2002 Jul; 241(2):385-9. PubMed ID: 12100866
[TBL] [Abstract][Full Text] [Related]
25. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.
Gordon S; Saupe A; McBurney W; Rades T; Hook S
J Pharm Pharmacol; 2008 Dec; 60(12):1591-600. PubMed ID: 19000363
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery.
Gordon S; Teichmann E; Young K; Finnie K; Rades T; Hook S
Eur J Pharm Sci; 2010 Oct; 41(2):360-8. PubMed ID: 20633644
[TBL] [Abstract][Full Text] [Related]
27. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
28. Oligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunity.
Kojima N; Biao L; Nakayama T; Ishii M; Ikehara Y; Tsujimura K
J Control Release; 2008 Jul; 129(1):26-32. PubMed ID: 18485512
[TBL] [Abstract][Full Text] [Related]
29. Solid lipid extrusion of sustained release dosage forms.
Reitz C; Kleinebudde P
Eur J Pharm Biopharm; 2007 Sep; 67(2):440-8. PubMed ID: 17481868
[TBL] [Abstract][Full Text] [Related]
30. Safety of intranasally administered archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) vaccine in mice.
Patel GB; Ponce A; Zhou H; Chen W
Int J Toxicol; 2008; 27(4):329-39. PubMed ID: 18821397
[TBL] [Abstract][Full Text] [Related]
31. Self-assembling CpG DNA nanoparticles for efficient antigen delivery and immunostimulation.
Rattanakiat S; Nishikawa M; Takakura Y
Eur J Pharm Sci; 2012 Sep; 47(2):352-8. PubMed ID: 22771546
[TBL] [Abstract][Full Text] [Related]
32. In-vivo biodegradation of extruded lipid implants in rabbits.
Sax G; Kessler B; Wolf E; Winter G
J Control Release; 2012 Oct; 163(2):195-202. PubMed ID: 22964393
[TBL] [Abstract][Full Text] [Related]
33. Archaeosomes with encapsulated antigens for oral vaccine delivery.
Li Z; Zhang L; Sun W; Ding Q; Hou Y; Xu Y
Vaccine; 2011 Jul; 29(32):5260-6. PubMed ID: 21609747
[TBL] [Abstract][Full Text] [Related]
34. Injectable silicone implants as vaccine delivery vehicles.
Lofthouse SA; Kajihara M; Nagahara S; Nash A; Barcham GJ; Sedgmen B; Brandon MR; Sano A
Vaccine; 2002 Mar; 20(13-14):1725-32. PubMed ID: 11906759
[TBL] [Abstract][Full Text] [Related]
35. Quil A-lipid powder formulations releasing ISCOMs and related colloidal structures upon hydration.
Demana PH; Davies NM; Hook S; Rades T
J Control Release; 2005 Mar; 103(1):45-59. PubMed ID: 15710499
[TBL] [Abstract][Full Text] [Related]
36. Controlled release implants based on cast lipid blends.
Kreye F; Siepmann F; Zimmer A; Willart JF; Descamps M; Siepmann J
Eur J Pharm Sci; 2011 May; 43(1-2):78-83. PubMed ID: 21463679
[TBL] [Abstract][Full Text] [Related]
37. Characterization of protein-adjuvant coencapsulation in microparticles for vaccine delivery.
Mathew S; Lendlein A; Wischke C
Eur J Pharm Biopharm; 2014 Jul; 87(2):403-7. PubMed ID: 24747810
[TBL] [Abstract][Full Text] [Related]
38. Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
Slütter B; Bal SM; Que I; Kaijzel E; Löwik C; Bouwstra J; Jiskoot W
Mol Pharm; 2010 Dec; 7(6):2207-15. PubMed ID: 21043518
[TBL] [Abstract][Full Text] [Related]
39. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
[TBL] [Abstract][Full Text] [Related]
40. Release pathways of interferon α2a molecules from lipid twin screw extrudates revealed by single molecule fluorescence microscopy.
Sax G; Feil F; Schulze S; Jung C; Bräuchle C; Winter G
J Control Release; 2012 Sep; 162(2):295-302. PubMed ID: 22820452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
